Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NEOG Stock Forecast 2026-2027
$9.42
Current Price
$2.05B
Market Cap
Buy 2
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to NEOG Price Targets
+38.0%
To High Target of $13.00
+27.4%
To Median Target of $12.00
+16.8%
To Low Target of $11.00
NEOG Price Momentum
0.0%
1 Week Change
+12.7%
1 Month Change
+98.3%
1 Year Change
+34.8%
Year-to-Date Change
-17.6%
From 52W High of $11.43
+111.2%
From 52W Low of $4.46
📊 TOP ANALYST CALLS
Did NEOG Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Neogen is one of their latest high-conviction picks.
Latest NEOG Stock Price Targets & Analyst Predictions
Based on our analysis of 7 Wall Street analysts, NEOG has a neutral consensus with a median price target of $12.00 (ranging from $11.00 to $13.00). The overall analyst rating is Buy (7.5/10). Currently trading at $9.42, the median forecast implies a 27.4% upside. This outlook is supported by 2 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Subbu Nambi at Guggenheim, projecting a 38.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NEOG Analyst Ratings
2
Buy
2
Hold
0
Sell
NEOG Price Target Range
Low
$11.00
Average
$12.00
High
$13.00
Current: $9.42
Latest NEOG Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NEOG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 12, 2026 | Piper Sandler | David Westenberg | Neutral | Reiterates | $10.00 |
| Jan 9, 2026 | Guggenheim | Subbu Nambi | Buy | Maintains | $12.00 |
| Dec 10, 2025 | CJS Securities | Robert Labick | Market Outperform | Upgrade | $10.00 |
| Oct 16, 2025 | Piper Sandler | David Westenberg | Neutral | Reiterates | $6.50 |
| Sep 29, 2025 | CJS Securities | Robert Labick | Market Perform | Initiates | $10.00 |
| Jul 29, 2025 | William Blair | Brandon Vazquez | Market Perform | Downgrade | $N/A |
| Jun 30, 2025 | Guggenheim | Subbu Nambi | Buy | Maintains | $10.00 |
| Apr 22, 2025 | Piper Sandler | David Westenberg | Neutral | Maintains | $5.00 |
| Apr 14, 2025 | Piper Sandler | David Westenberg | Neutral | Maintains | $6.50 |
| Apr 10, 2025 | Guggenheim | Subbu Nambi | Buy | Maintains | $13.00 |
| Jan 21, 2025 | Piper Sandler | David Westenberg | Neutral | Reiterates | $13.00 |
| Dec 19, 2024 | Guggenheim | Subbu Nambi | Buy | Initiates | $15.00 |
| Aug 6, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.50 |
| Apr 15, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.00 |
| Jan 18, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $19.00 |
| Oct 16, 2023 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.50 |
| Aug 14, 2023 | Wells Fargo | Timothy Daley | Overweight | Maintains | $28.00 |
| Jun 16, 2023 | Wells Fargo | Timothy Daley | Overweight | Initiates | $22.00 |
| Dec 15, 2022 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.00 |
| Nov 22, 2022 | William Blair | Brandon Vazquez | Outperform | Upgrade | $N/A |
Neogen Corporation (NEOG) Competitors
The following stocks are similar to Neogen based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Neogen Corporation (NEOG) Financial Data
Neogen Corporation has a market capitalization of $2.05B with a P/E ratio of 865.0x. The company generates $870.56M in trailing twelve-month revenue with a -69.9% profit margin.
Revenue growth is -4.4% quarter-over-quarter, while maintaining an operating margin of -1.6% and return on equity of -25.6%.
Valuation Metrics
Market Cap
$2.05B
Enterprise Value
$2.69B
P/E Ratio
865.0x
PEG Ratio
14.8x
Price/Sales
2.4x
Growth & Margins
Revenue Growth (YoY)
-4.4%
Gross Margin
+46.9%
Operating Margin
-1.6%
Net Margin
-69.9%
EPS Growth
-4.4%
Financial Health
Cash/Price Ratio
+7.8%
Current Ratio
3.9x
Debt/Equity
37.8x
ROE
-25.6%
ROA
-0.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Neogen Corporation (NEOG) Business Model
About Neogen Corporation
What They Do
Develops products for food and animal safety.
Business Model
Neogen Corporation operates through two segments: Food Safety and Animal Safety. It generates revenue by providing diagnostic test kits, culture media, and various solutions that help detect pathogens and toxins in food and animal feed, alongside a range of veterinary products and services.
Additional Information
Founded in 1981 and headquartered in Lansing, Michigan, Neogen plays a crucial role in improving global food security and animal health standards. Its diverse offerings support various sectors including agriculture and veterinary services.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
2,974
CEO
Mr. Mikhael Nassif
Country
United States
IPO Year
1994
Website
www.neogen.comNeogen Corporation (NEOG) Latest News & Analysis
Latest News
Quick Summary
Neogen Corp (NASDAQ:NEOG) shares declined approximately 3% on Thursday following the release of its third-quarter financial results.
Why It Matters
Neogen Corp's 3% share decline signals potential concerns over its third-quarter performance, impacting investor sentiment and possibly future stock value.
Source: Benzinga
Market Sentiment:
Negative
Quick Summary
Neogen's animal safety business is negatively impacting earnings due to setbacks from third-party sources.
Why It Matters
Neogen's animal safety business underperformance may impact overall earnings, raising concerns about future profitability and affecting stock performance.
Source: Barrons
Market Sentiment:
Negative
Quick Summary
Neogen Corporation (NEOG) held its Q3 2026 earnings call, providing insights into its financial performance and future outlook. Further details can be found in the full transcript.
Why It Matters
The Q3 2026 earnings call for Neogen Corporation (NEOG) provides insights into the company's financial performance, growth prospects, and market trends, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Neogen Corporation (NASDAQ: NEOG) reported its fiscal Q3 2026 results, highlighting progress in its strategic transformation and growth in the Food Safety segment. Full fiscal year guidance updated.
Why It Matters
Neogen's strong core growth in the Food Safety segment and updated financial guidance indicate a positive outlook, potentially boosting investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Neogen (NEOG) reported quarterly earnings of $0.09 per share, exceeding the Zacks Consensus Estimate of $0.04. This is a decline from $0.10 per share in the same quarter last year.
Why It Matters
Neogen's earnings beat estimates, indicating stronger performance than expected, but a decline from last year may raise concerns about growth potential.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Neogen (NEOG) reported its revenue and EPS for Q1 2026. Investors should compare these figures with Wall Street estimates and year-ago metrics for better insights.
Why It Matters
Neogen's revenue and EPS performance relative to Wall Street estimates and year-ago figures can indicate growth trends and market expectations, influencing stock valuation and investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About NEOG Stock
What is Neogen Corporation's (NEOG) stock forecast for 2026?
Based on our analysis of 7 Wall Street analysts, Neogen Corporation (NEOG) has a median price target of $12.00. The highest price target is $13.00 and the lowest is $11.00.
Is NEOG stock a good investment in 2026?
According to current analyst ratings, NEOG has 2 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $9.42. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NEOG stock?
Wall Street analysts predict NEOG stock could reach $12.00 in the next 12 months. This represents a 27.4% increase from the current price of $9.42. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Neogen Corporation's business model?
Neogen Corporation operates through two segments: Food Safety and Animal Safety. It generates revenue by providing diagnostic test kits, culture media, and various solutions that help detect pathogens and toxins in food and animal feed, alongside a range of veterinary products and services.
What is the highest forecasted price for NEOG Neogen Corporation?
The highest price target for NEOG is $13.00 from Subbu Nambi at Guggenheim, which represents a 38.0% increase from the current price of $9.42.
What is the lowest forecasted price for NEOG Neogen Corporation?
The lowest price target for NEOG is $11.00 from at , which represents a 16.8% increase from the current price of $9.42.
What is the overall NEOG consensus from analysts for Neogen Corporation?
The overall analyst consensus for NEOG is neutral. Out of 7 Wall Street analysts, 2 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $12.00.
How accurate are NEOG stock price projections?
Stock price projections, including those for Neogen Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 22, 2026 12:32 PM UTC